Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies

FEBS Letters

Volumn 588, Issue 1, 2014, Pages 151-159

  Schipper Krom, Sabine ^a   Juenemann, Katrin ^a   Jansen, Anne H ^a   Wiemhoefer, Anne ^a   Van Den Nieuwendijk, Rianne ^b   Smith, Donna L ^c   Hink, Mark A ^d   Bates, Gillian P ^c   Overkleeft, Hermen ^b   Ovaa, Huib ^e   Reits, Eric ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Aggregate; Huntington; Polyglutamine; Proteasome; Ubiquitin

Indexed keywords

POLYGLUTAMINE; PROTEASOME;

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL ASSAY; CELL INCLUSION; CELL LABELING; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 84890988864     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.11.023     Document Type: Article

References (31)

1. M. DiFiglia, E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, J.P. Vonsattel, and N. Aronin Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1997 1990 1993
2. C.A. Ross Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19 1997 1147 1150
3. S.W. Davies et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 1997 537 548
4. E. Rousseau, R. Kojima, G. Hoffner, P. Djian, and A. Bertolotti Misfolding of proteins with a polyglutamine expansion is facilitated by proteasomal chaperones J. Biol. Chem. 284 2009 1917 1929
5. S. Waelter, A. Boeddrich, R. Lurz, E. Scherzinger, G. Lueder, H. Lehrach, and E.E. Wanker Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation Mol. Biol. Cell 12 2001 1393 1407
6. C.J. Cummings, M.A. Mancini, B. Antalffy, D.B. DeFranco, H.T. Orr, and H.Y. Zoghbi Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 Nat. Genet. 19 1998 148 154
7. N.R. Jana, E.A. Zemskov, G. Wang, and N. Nukina Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release Hum. Mol. Genet. 10 2001 1049 1059
8. A. McCampbell, and K.H. Fischbeck Polyglutamine and CBP: fatal attraction? Nat. Med. 7 2001 528 530
9. C.I. Holmberg, K.E. Staniszewski, K.N. Mensah, A. Matouschek, and R.I. Morimoto Inefficient degradation of truncated polyglutamine proteins by the proteasome EMBO J. 23 2004 4307 4318
10. M. Raspe, J. Gillis, H. Krol, S. Krom, K. Bosch, H. van Veen, and E. Reits Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity J. Cell Sci. 122 2009 3262 3271
11. P. Venkatraman, R. Wetzel, M. Tanaka, N. Nukina, and A.L. Goldberg Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins Mol. Cell 14 2004 95 104
12. E.J. Bennett, N.F. Bence, R. Jayakumar, and R.R. Kopito Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation Mol. Cell 17 2005 351 365
13. M. Diaz-Hernandez, A.G. Valera, M.A. Moran, P. Gomez-Ramos, B. Alvarez-Castelao, J.G. Castano, F. Hernandez, and J.J. Lucas Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain J. Neurochem. 98 2006 1585 1596
14. H. Seo, K.C. Sonntag, and O. Isacson Generalized brain and skin proteasome inhibition in Huntington's disease Ann. Neurol. 56 2004 319 328
15. J.S. Bett, C. Cook, L. Petrucelli, and G.P. Bates The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington's disease PLoS ONE 4 2009 e5128
16. C.J. Maynard et al. Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment Proc. Natl. Acad. Sci. USA 106 2009 13986 13991
17. Z. Ortega, M. Diaz-Hernandez, C.J. Maynard, F. Hernandez, N.P. Dantuma, and J.J. Lucas Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation J. Neurosci. 30 2010 3675 3688
18. B.R. Martin, B.N. Giepmans, S.R. Adams, and R.Y. Tsien Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity Nat. Biotechnol. 23 2005 1308 1314
19. B.I. Florea et al. Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit beta5t Chem. Biol. 17 2010 795 801
20. C.R. Berkers, F.W. van Leeuwen, T.A. Groothuis, V. Peperzak, E.W. van Tilburg, J. Borst, J.J. Neefjes, and H. Ovaa Profiling proteasome activity in tissue with fluorescent probes Mol. Pharm. 4 2007 739 748
21. E. Hockly, B. Woodman, A. Mahal, C.M. Lewis, and G. Bates Standardization and statistical approaches to therapeutic trials in the R6/2 mouse Brain Res. Bull. 61 2003 469 479
22. K. Sathasivam et al. Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease Hum. Mol. Genet. 19 2010 65 78
23. L. Mangiarini et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 87 1996 493 506
24. K. Sathasivam et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease Proc. Natl. Acad. Sci. USA 110 2013 2366 2370
25. A. Lunkes, K.S. Lindenberg, L. Ben-Haiem, C. Weber, D. Devys, G.B. Landwehrmeyer, J.L. Mandel, and Y. Trottier Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions Mol. Cell 10 2002 259 269
26. E.S. Johnson, P.C. Ma, I.M. Ota, and A. Varshavsky A proteolytic pathway that recognizes ubiquitin as a degradation signal J. Biol. Chem. 270 1995 17442 17456
27. J. Gillis et al. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides J. Biol. Chem. 288 2013 17225 17237
28. M. Arrasate, S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810
29. S. Mitra, A.S. Tsvetkov, and S. Finkbeiner Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease J. Biol. Chem. 284 2009 4398 4403
30. M.S. Hipp, C.N. Patel, K. Bersuker, B.E. Riley, S.E. Kaiser, T.A. Shaler, M. Brandeis, and R.R. Kopito Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease J. Cell Biol. 196 2012 573 587
31. K. Juenemann, S. Schipper-Krom, A. Wiemhoefer, A. Kloss, A. Sanz Sanz, and E.A. Reits Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes J. Biol. Chem. 288 2013 27068 27084